PETALコンソーシアムの世界的な研究

基本情報

NCT ID

NCT06067347

ステータス

募集中

試験のフェーズ

-

試験タイプ

観察

目標被験者数

1,200

治験依頼者名

Massachusetts General Hospital

概要

The goal of this observational study is to correlate molecular alterations with outcomes including overall survival (OS), progression-free survival (PFS), response rates for patients with a new diagnosis, primary refractory or relapse, of mature T-cell and NK-cell neoplasms (TNKL). We hypothesize that machine learning can be leveraged to uncover distinct genetic vulnerabilities that underlie treatment response and resistance for patients with TNKL, thus moving towards personalized treatment solutions.

対象疾患

依頼者（Sponsor）

実施施設 (2)